The global Microbiome Therapeutics Market was valued at USD 132.94 million in 2023 and is poised to reach an estimated USD 1,979.94 million by 2031, marking a remarkable compound annual growth rate (CAGR) of 40.16% from 2024 to 2031. This exponential growth is driven by the increasing focus on the human microbiome, technological advancements in microbiome research, rising prevalence...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian